3 Growth Companies With Insider Ownership Up To 15%

As global markets show signs of recovery with cooling inflation and strong bank earnings propelling U.S. stocks higher, investors are increasingly attentive to growth companies that demonstrate resilience in such fluctuating conditions. A key factor in evaluating these companies is insider ownership, as it often indicates confidence from those who know the business best, aligning their interests with shareholders and potentially enhancing long-term value creation.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Kirloskar Pneumatic (BSE:505283)	30.3%	26.3%
Clinuvel Pharmaceuticals (ASX:CUV)	10.4%	26.2%
Propel Holdings (TSX:PRL)	36.8%	38.9%
Medley (TSE:4480)	34%	27.2%
On Holding (NYSE:ONON)	19.1%	29.7%
Fine M-TecLTD (KOSDAQ:A441270)	17.2%	131.1%
Elliptic Laboratories (OB:ELABS)	26.8%	121.1%
Fulin Precision (SZSE:300432)	13.6%	66.7%
HANA Micron (KOSDAQ:A067310)	18.3%	110.9%
Findi (ASX:FND)	35.8%	112.9%

Click here to see the full list of 1477 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Henan Shijia Photons Technology (SHSE:688313)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Henan Shijia Photons Technology Co., Ltd. operates in the photonics industry and has a market cap of CN¥8.72 billion.

Operations: The company's revenue primarily comes from its Optical Networking Equipments segment, totaling CN¥942.76 million.

Insider Ownership: 10.6%

Henan Shijia Photons Technology is positioned for significant growth, with revenue expected to increase by 22.1% annually, outpacing the Chinese market's 13.4% growth rate. Earnings are projected to grow at a remarkable 65.9% per year, well above the market average of 25.2%. Despite high volatility in its share price and low forecasted return on equity (9.2%), the company's recent profitability and substantial insider ownership suggest confidence in its long-term potential.

• Click here and access our complete growth analysis report to understand the dynamics of Henan Shijia Photons Technology.
• The analysis detailed in our Henan Shijia Photons Technology valuation report hints at an inflated share price compared to its estimated value.

BayCurrent Consulting (TSE:6532)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BayCurrent Consulting, Inc. offers consulting services in Japan and has a market cap of approximately ¥895.93 billion.

Operations: BayCurrent Consulting, Inc. generates its revenue from consulting services provided within Japan.

Insider Ownership: 13.9%

BayCurrent Consulting is trading 39.2% below its estimated fair value, suggesting potential undervaluation. Earnings are forecast to grow at 17.95% annually, outpacing the Japanese market's average of 8.1%. Despite high share price volatility recently, the company's return on equity is projected to reach a robust 35% within three years. Revenue growth of 17.9% per year exceeds the broader market's rate but remains below significant growth thresholds. No substantial insider trading activity noted recently.

• Unlock comprehensive insights into our analysis of BayCurrent Consulting stock in this growth report.
• According our valuation report, there's an indication that BayCurrent Consulting's share price might be on the expensive side.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates as an online pharmacy across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.43 billion.

Operations: The company's revenue segments include €1.82 billion from the DACH region and €410.50 million from international markets.

Insider Ownership: 15.6%

Redcare Pharmacy is trading at 78.5% below its estimated fair value, indicating potential undervaluation. The company is expected to achieve profitability within three years, with earnings projected to grow 62.56% annually, surpassing the German market's average growth rate. Recent insider activity shows more buying than selling, though not in significant volumes. Despite revenue growing by 16% per year and increasing sales figures, the net loss widened to €18.98 million for the first nine months of 2024.

• Click to explore a detailed breakdown of our findings in Redcare Pharmacy's earnings growth report.
• Our expertly prepared valuation report Redcare Pharmacy implies its share price may be too high.

Where To Now?

• Investigate our full lineup of 1477 Fast Growing Companies With High Insider Ownership right here.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com